CIK 0001601485
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113430072
- Phone
- +1 857-209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 10-K Report Annual Report
- 8-K Event Material agreement · Agreement ended
- 8-K Event Material agreement · Executive or director change · Other events
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs · Executive or director change
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Results of operations · Exit or restructuring costs
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Agreement ended
Page 5 of 6 · 109 filings